Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 320 of 5804
-
Four brain chips could let paralyzed people control computers with thought alone
Disease control Recruiting nowThis research study is being done to develop a novel brain-computer interface (BCI) technology that can enable severely paralyzed individuals to interact with the world through direct brain-control of a computer. This technology is named MindEx (for Mind Extender). It utilizes fo…
Phase: NA • Sponsor: Nader Pouratian • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Stem cell shot may keep dialysis lifeline open for kidney patients
Disease control Not yet recruitingA Study on the Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Universal CAR-T cells take on lupus and more in early trial
Disease control Recruiting nowA single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA U CAR T cells in patients with autoimmune diseases. 60 patients are planned to be enrolled in the dose-escalation trial.
Phase: EARLY_PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Spinal stimulation plus step training shows promise for walking recovery
Disease control Recruiting nowA well-established rehabilitation strategy for improvements of standing and walking ability in persons with spinal cord injury (SCI) is step training on a motorized treadmill with body weight support. A promising intervention is stimulation of the spinal cord through the skin (tr…
Phase: NA • Sponsor: Maria Knikou, PT, MBA, PhD • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New eye injection could restore sight in corneal swelling patients
Disease control Recruiting nowThe purpose of this study is to assess the efficacy and safety of single injection dose of AURN001 compared with placebo in adult participants with corneal edema secondary to corneal endothelial dysfunction.
Phase: PHASE3 • Sponsor: Aurion Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for hard-to-treat lung cancer: drug combo targets resistant tumors
Disease control Recruiting nowThis phase II trial tests how well telisotuzumab vedotin and osimertinib works for the treatment of non small cell lung cancer that is growing, spreading, or getting worse (progressive) and for which no treatment is currently available (incurable). Telisotuzumab vedotin is a mono…
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Can early rhythm control save hearts in AF patients with leaky valves?
Disease control Recruiting nowAtrial fibrillation is frequently accompanied by tricuspid regurgitation and may contribute to right atrial and tricuspid annular remodeling, leading to progression of tricuspid regurgitation and adverse clinical outcomes. However, whether early rhythm control improves prognosis …
Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a common arthritis drug tame a rare, fatal blood vessel disease?
Disease control Recruiting nowBackground: Kohlmeier-Degos (KD) is a rare disease that causes inflammation and blood clots, leading to blockages in small blood vessels. These blockages can result in K-D lesions throughout the body, affecting the skin, lungs, heart, spinal cord, and brain. KD can be fatal. No …
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for Hard-to-Treat myeloma: experimental combo enters phase 2
Disease control Recruiting nowThis is a Phase 2, open-label, single-arm, multicenter study to assess the antimyeloma activity and further characterize the safety, tolerability, PK, and PD of cemsidomide in combination with dexamethasone in participants with relapsed/refractory multiple myeloma (r/r MM).
Phase: PHASE2 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New shot could train body to tolerate peanuts
Disease control Recruiting nowThis study will test a new investigational treatment called UKK-0018. UKK-0018 as an immunotherapeutic for the treatment of peanut allergies. The treatment is given by injection and is designed to train the immune system to tolerate peanut exposure over time.
Phase: PHASE1, PHASE2 • Sponsor: Ukko Inc • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Smartwatch and app join fight against metastatic breast cancer
Disease control Recruiting nowThis is an open-label, single arm, non-randomized, multicenter, phase 2 study assessing the efficacy and safety of T-DXd as first-line treatment in HER2-positive advanced/metastatic BC patients (N=300). The study integrates digital health tools for proactive toxicity management a…
Phase: PHASE2 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo aims to shrink hard-to-treat breast tumors
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of inavolisib in combination with fulvestrant compared with inavolisib in combination with fulvestrant in participants with PIK3CA-mutated, HR-positive, HER2-negative locally advanced or metastatic breast cancer (LA…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental CAR-T therapy targets tough lymphoma in early trial
Disease control Recruiting nowThe goal of this clinical research study is to find the highest tolerable dose of JV-394 (a type of autologous CAR-T cell therapy) that can be given to patients who have T/NK cell lymphoma that is relapsed or refractory. The safety and possible side effects of JV-394 will also be…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can an herbal formula boost lung cancer treatment?
Disease control ENROLLING_BY_INVITATIONGlobally, lung cancer stands as the foremost cause of cancer-related mortality. Among its subtypes, small cell lung cancer (SCLC) represents an exceptionally aggressive malignancy, accounting for approximately 15-20% of all lung cancer cases. Over two-thirds of SCLC patients are …
Phase: NA • Sponsor: LI FENG • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New eye implant could replace daily glaucoma drops
Disease control Recruiting nowEvaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Phase: PHASE3 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a new drug combo tame pancreatic cancer and prevent clots?
Disease control Recruiting nowThis phase I/II trial tests the effect of pegcetacoplan in combination with oxaliplatin, irinotecan, leucovorin, and fluorouracil (mFOLFIRINOX) in treating patients with pancreatic ductal adenocarcinoma (PDAC) that has spread from where it first started (primary site) to other pl…
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Home HIV shots by loved ones could revolutionize care
Disease control ENROLLING_BY_INVITATIONThis study will support the expansion of long-acting injectable antiretroviral therapy (LAI-ART) in non-clinical settings by developing, implementing, and evaluating a comprehensive, theory-informed training intervention to support the administration of LAI-ART by a trained laype…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New imaging tool aims to free Long-Term ventilator patients faster
Disease control Recruiting nowPatients with prolonged mechanical ventilation (PMV) frequently experience impaired ventilation distribution, respiratory muscle dysfunction, secretion retention, and delayed liberation from mechanical ventilation. Electrical impedance tomography (EIT) provides real-time bedside …
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Liver cancer trial adds a resistance-blocker to standard chemo – could it boost success?
Disease control Recruiting nowIMPACT-TACE is an investigator-initiated, prospective, multicenter, randomized, double-blinded, interventional trial to test the hypothesis that the simultaneous application of doxorubicin with the ABCB1 inhibitor nicardipine would significantly improve the success rate of TACE t…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New eye drug could cut injection frequency for Diabetes-Related vision loss
Disease control Recruiting nowThis is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC